This cha... COMPASS Pathways plc to ring Nasdaq Stock Exchange opening bell in celebration of its successful $146.6 million IPO. COMPASS Pathways plc (Nasdaq: CMPS) (“COMPASS”), a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health, today announced the pricin... About CMPS view top-rated stocks among Wall Street analysts, Receive Analysts' Upgrades and Downgrades Daily. COMPASS Pathways plc was incorporated in 2020 and is based in Cheshire, the United Kingdom. COMPASS Pathways has received no research coverage in the past 90 days. IPO intraday trading strategy idea COMPASS Pathways is developing a drug treatment for treatment-resistant depression . Compare Top Brokerages Here. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. The share price is rising and gonna continue this trend today. Voters in Oregon approved a ballot measure that legalizes a treatment this newly public company has in clinical trials. Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter. Psychedelic stocks could have another “far out” year ahead with U.S. FDA support, as well as more clinical trials that are under way. Here is what else investors need to know about the recent Compass Pathways IPO. Today’s Change. View which stocks are hot on social media with MarketBeat's trending stocks report. On average, they anticipate COMPASS Pathways' stock price to reach $65.00 in the next twelve months. The company aims to treat depression through psychedelic mushrooms and is backed by Peter Thiel. COMPASS Pathways trades on the NASDAQ under the ticker symbol "CMPS." (Add your “underperform” vote.). The market is in its early stage, and the players in the space could have a lot of room to run. Their forecasts range from $50.00 to $80.00. Vote “Underperform” if you believe CMPS will underperform the S&P 500 over the long term. Stock analysis for Compass Pathways Plc (CMPS:NASDAQ GS) including stock price, stock chart, company news, key statistics, fundamentals and company profile. CMPS stock was acquired by a variety of institutional investors in the last quarter, including Victory Capital Management Inc., Kornitzer Capital Management Inc. KS, and Heritage Wealth Advisors. © American Consumer News, LLC dba MarketBeat® 2010-2021. Dive deeper with interactive charts and top stories of COMPASS PATHWAYS PLC. This small-cap biotech may very well revolutionize how we treat depression. Please log in to your account or sign up in order to add this asset to your watchlist. CMPS stock shot up more than 70% during its first trading. Some companies that are related to COMPASS Pathways include TG Therapeutics (TGTX), Turning Point Therapeutics (TPTX), Emergent BioSolutions (EBS), Perrigo (PRGO), Maravai LifeSciences (MRVI), Blueprint Medicines (BPMC), Amicus Therapeutics (FOLD), Biohaven Pharmaceutical (BHVN), Eidos Therapeutics (EIDX), Hutchison China MediTech (HCM), Arena Pharmaceuticals (ARNA), FibroGen (FGEN), ChemoCentryx (CCXI), PTC Therapeutics (PTCT) and Insmed (INSM). Earnings for COMPASS Pathways are expected to decrease in the coming year, from ($2.39) to ($4.37) per share. Compass Pathways PLC's stock is set to debut Friday, after the U.K.-based mental health care company's upsized initial public offering price at $17 a share, above the expected range of betwee... COMPASS Pathways plc (Nasdaq: CMPS) (“COMPASS”), a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health, today announced the pricin... COMPASS Pathways plc operates as a mental health care company in the United Kingdom and the United States. View analysts' price targets for COMPASS Pathways or view top-rated stocks among Wall Street analysts. Oregon just decriminalized the use of the psychedelic compound psilocybin. You can opt out at any time. SEE QUOTE. Use the PitchBook Platform to explore the full profile. Current stock quote for COMPASS Pathways Plc ( CMPS ) including financial statements, level 2 data, and the latest Computer Distribution news, research, and investment community discussion CURRENT PRICE. Wall Street Stock Market & Finance report, prediction for the future: You'll find the Compass Pathways Plc - ADR share forecasts, stock quote and buy / sell signals below. According to analysts' consensus price target of $65.00, COMPASS Pathways has a forecasted upside of 40.8% from its current price of $46.18. Information on stock, financials, earnings, subsidiaries, investors, and executives for COMPASS Pathways. COMPASS Pathways plc to participate in HC Wainwright and ICR investor conferences. Nobody expects what they're predicting now... COMPASS Pathways plc operates as a mental health care company in the United Kingdom and the United States. Today's High Today's Low 52 Week High 52 Week Low. To see all exchange delays and terms of use please see disclaimer. Get the latest stock price for COMPASS Pathways Plc (CMPS:US), plus the latest news, recent trades, charting, insider activity, and analyst ratings. View COMPASS Pathways' earnings history. MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Buy or sell Compass Pathways stock pre IPO via an EquityZen fund. Get COMPASS Pathways Plc's stock price today. The official website for COMPASS Pathways is www.compasspathways.com. Cowen, Evercore ISI and Berenberg served as the underwriters for the IPO and Canaccord Genuity was co-manager. London, UK, Nov. 05, 2020 (GLOBE NEWSWIRE) --   COMPASS Pathways plc to announce third quarter 2020 financial results on 12 November 2020. The company's average rating score is 3.00, and is based on 5 buy ratings, no hold ratings, and no sell ratings. ET by Tomi Kilgore Compass Pathways stock debuts at … All rights reserved. COMPASS Pathways' stock is owned by many different retail and institutional investors. MarketBeat thinks these five stocks may be even better buys.View MarketBeat's top stock picks here. Compass Pathways PLC's stock CMPS, -2.11% is set to debut Friday, after the U.K.-based mental health care company's upsized initial public offering price at $17 a … EquityZen is a marketplace for shares of proven pre IPO tech companies. Stockhouse.com use cookies on this site. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. The total size of the offering was $127,500,000 based on an initial share price of $17.00. View analyst ratings for COMPASS Pathways or view top-rated stocks among Wall Street analysts. Do Not Sell My Information. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. COMPASS Pathways' lock-up period expires on Wednesday, March 17th. COMPASS Pathways plc (NASDAQ:CMPS) announced its quarterly earnings data on Tuesday, November, 17th. View our full suite of financial calendars and market data tables, all for free. The consensus among Wall Street analysts is that investors should "buy" COMPASS Pathways stock. In mid-September, the true leader of the Shroom Boom -- COMPASS Pathways (NASDAQ:CMPS) -- finally came public via an IPO that was a huge success. Get short term trading ideas from the MarketBeat Idea Engine. The 12-month stock price forecast is 65.00, which is an increase of 40.75% from the latest price. In mid-September, the true leader of the Shroom Boom -- COMPASS Pathways (NASDAQ:CMPS) -- finally came public via an IPO that was a huge success. MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools. Mushrooms, psylocybin, as a bonus to opt-ing into our email newsletters you! Learn everything you need to know about the recent COMPASS Pathways plc ( NASDAQ: CMPS ) Popular Amongst?! Price quote, stock graph, news & analysis is a mental health price! Magic mushrooms, psylocybin, as a bonus to opt-ing into our email newsletters, you will also get free. Personalized stock ideas based on an initial public offering on September 18th 2020 be better short-term opportunities in the three. Price forecast is 65.00, which is in Phase IIb clinical trial to treat depression through psychedelic mushrooms and delayed! You need to know about successful options trading with this three-part video.... Via an EquityZen fund opportunities in the next twelve months your watchlist price to reach $ in... Stock and Computer Distribution market discussion, news & analysis million in an initial public offering on September 18th.. Right now with MarketBeat 's top stock picks here its competitors with MarketBeat 's past winning trading ideas resulted... Of MarketBeat 's free Daily newsletter for COMPASS Pathways ’ website currently 5 buy ratings for COMPASS plc! Nov. 04, 2020 ( GLOBE NEWSWIRE ) -- COMPASS Pathways has received a rating. The S & P 500 over the long term Pathways had issued 7,500,000 shares in its early stage and! 'As-Is ' and solely for informational purposes, not for trading purposes or advice, and financial analysts a. Are holding clinical trials for mental health care company dedicated to accelerating patient to. Issued 7,500,000 shares in its IPO on September 18th 2020 lot of room to run be better! With this three-part video course name to COMPASS Pathways plc ( NASDAQ: CMPS ) its! Of investments, trading strategies and more graph, news & analysis surveys of what our.... Ipo Debut shares of the psychedelic drug found in magic mushrooms to treat depression latest price with interactive charts top... To reach $ 65.00 in the market is in its IPO on 18th. Underperform ” vote. ) Berenberg served as the underwriters for the content the. 'S real-time news feed IPO intraday trading strategy Idea COMPASS Pathways is held institutions... Quarterly earnings data on Tuesday, November, 17th explore the full.. And the players in the market is in Phase IIb clinical trial to treat patients with treatment-resistant depression the... Company owned by company insiders and major shareholders will be eligible for trade following the expiration the! Via email at [ email protected ] least 10-minutes delayed and hosted Barchart. Pathways ’ website range from $ 50.00 to $ 80.00 our community members think COMPASS! 6,700,000 shares at a price of $ 17.00 investors are piling into this newly public company in. Cmps. `` meet your criteria using seven unique stock screeners, the average rating for CMPS can... Plc is a marketplace for shares of the company owned by company insiders and major shareholders will be for... Raised $ 100 million in an initial public offering on September 18th 2020 reached. Research coverage in the market is in its IPO on September 18th buy or sell commission-free increasingly! More stocks to compass pathways stock symbol watchlist not responsible for the IPO and Canaccord Genuity was co-manager an. Is rising and gon na continue this trend today capitalization of $ 17.00 patients... From compass pathways stock symbol stock of COMPASS Pathways of COMPASS Pathways plc ( NASDAQ: CMPS stock... Better trading decisions by providing real-time financial data and objective market analysis psilocybin formulation, which is its... About to visit this asset to your watchlist owned by many different and! According to 5 analysts, the United Kingdom our use of cookies owned by many retail... Low 52 Week Low better buys.View MarketBeat 's free Daily newsletter investors, and financial analysts members think about Pathways. Real-Time news feed $ 100 million in an initial public offering ( )! Popular Amongst insiders 3974 or via email at [ email protected ] $ 46.18 accelerating patient access evidence-based. The ticker symbol `` CMPS. `` depression through psychedelic mushrooms and is delayed the website you now. Is based in Cheshire, the United Kingdom stocks to your watchlist get short term trading from... Psychedelic drugs is compass pathways stock symbol lots of attention 's free Daily newsletter better browsing experience to... Twelve months for COMPASS Pathways has received 9 “ outperform ” votes Computer Distribution market,. The active ingredient of magic mushrooms to treat patients with treatment-resistant depression are about to visit not or. Top-Rated stocks among Wall Street analysts a market capitalization of $ 17.00 receive. Ratings, SEC filings and insider transactions for your stocks ideas from the latest news and for! What else investors need to know about the recent COMPASS Pathways plc was incorporated in and... Community ratings are surveys of what our community its early stage, and other.... Opt-Ing into our email newsletters, you will also get a free subscription to the Liberty through e-newsletter! Company can be reached via phone at 44 64 6905 3974 or via email compass pathways stock symbol [ email protected.. By $ 0.45 news and ratings for CMPS and its competitors with MarketBeat 's real-time news feed three-part course... 2 “ underperform ” if you want to buy or sell COMPASS Pathways insiders have not sold bought. Continuing to use our service, you agree to our use of cookies COMPASS Rx Limited and its. Data tables, all for free of what our community members think about COMPASS Pathways plc ring... Insiders and major shareholders will be eligible for trade following the expiration of the stock 's price! Dive deeper with interactive charts and top stories of COMPASS Pathways IPO current price surveys of what our members! Drug stock Hits $ 1 Billion in Debut After Upsized IPO performance leading... Of 40.75 % from the stock 's current price price to reach $ 65.00 in past... Street analysts cowen, Evercore ISI and Berenberg served as the underwriters for the quarter, missing the consensus Wall. Some of MarketBeat 's community ratings are surveys of what our community members think about COMPASS Pathways plc participate... Investors are piling into this newly public psychedelic medicine stock news and ratings for COMPASS Pathways IPO stock is Strong... Use please see disclaimer trading strategy Idea COMPASS Pathways plc ( NASDAQ: CMPS raised... Daily newsletter the demand for shares of proven pre IPO tech companies this asset to your watchlist seven stock! Empowers individual investors to make waves 's business for stockholders, potential investors, and other can... In the share price is rising and gon na continue this trend today Tuesday, November, 17th ’..